Nancy Stagliano

Director at Latigo Biotherapeutics.

Thousand Oaks, CA
Latigo Biotherapeutics

Raised on Latigo Biotherapeutics filings

$50M

of $150M offered across 1 Form D filing

Form D filings: 1
Teammates: 7
Last filing: Feb 13, 2025

Company

Latigo Biotherapeutics

Biotech · Thousand Oaks, CA

Non-opioid pain medicines

Non-opioid pain medicines

Investors: 7
Still open: $100M

Investors: 7
Sector: Biotech
HQ: Thousand Oaks, CA

Latigo Biotherapeutics filings

Latigo Biotherapeutics Form D filings
Filed	Security	Sold of offered	Filing
Feb 13, 2025	Equity	$50M/ $150M	Form D

EquityFiled Feb 13, 2025Form D
$50M/ $150M

Works with

Also named on Latigo Biotherapeutics filings

Tim LugoChief Financial Officer, Form D signerForm D signer Beth SeidenbergDirector Deborah PalestrantDirector Jim TananbaumDirector Kevin RaidyDirector Nima FarzanExecutive Officer, Director Tim WalbertDirector